Visit (Number) vs Paced Auditory Serial Addition Task (PASAT) Total Dyad Responses - 1.6 second trial
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline (BL) | - | - | - | - | - | - | 1,516 | 1,516 |
Clinical Evaluation (CE) | - | - | - | - | - | - | 1,516 | 1,516 |
Diagnostic Visit (DX) | 1,105 | 23.4 | ± 15.7 | 22.0 | -3.0 | 59.0 | 411 | 1,516 |
CPAP Titration Visit (CPAP) | - | - | - | - | - | - | 1,516 | 1,516 |
Two Month Post-CPAP Neurocognitive Visit (2M) | 1,105 | 17.1 | ± 18.3 | 16.0 | -7.0 | 59.0 | 411 | 1,516 |
Four Month Post-CPAP Neurocognitive Visit (4M) | - | - | - | - | - | - | 1,516 | 1,516 |
Six Month Post-CPAP Neurocognitive Visit (6M) | 1,105 | 16.7 | ± 18.9 | 15.0 | -7.0 | 59.0 | 411 | 1,516 |
Gender vs Paced Auditory Serial Addition Task (PASAT) Total Dyad Responses - 1.6 second trial
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Paced Auditory Serial Addition Task (PASAT) Total Dyad Responses - 1.6 second trial
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Paced Auditory Serial Addition Task (PASAT) Total Dyad Responses - 1.6 second trial
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 23.4 | ± 15.7 | 22.0 | -3.0 | 59.0 | 411 | 1,516 |
Male | 723 | 25.1 | ± 16.0 | 24.0 | -3.0 | 59.0 | 235 | 958 |
Female | 382 | 20.3 | ± 14.6 | 19.0 | -3.0 | 59.0 | 176 | 558 |
Gender vs Paced Auditory Serial Addition Task (PASAT) Total Dyad Responses - 1.6 second trial
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Paced Auditory Serial Addition Task (PASAT) Total Dyad Responses - 1.6 second trial
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 17.1 | ± 18.3 | 16.0 | -7.0 | 59.0 | 411 | 1,516 |
Male | 723 | 18.0 | ± 18.8 | 17.0 | -7.0 | 59.0 | 235 | 958 |
Female | 382 | 15.4 | ± 17.2 | 13.5 | -7.0 | 59.0 | 176 | 558 |
Gender vs Paced Auditory Serial Addition Task (PASAT) Total Dyad Responses - 1.6 second trial
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Paced Auditory Serial Addition Task (PASAT) Total Dyad Responses - 1.6 second trial
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 16.7 | ± 18.9 | 15.0 | -7.0 | 59.0 | 411 | 1,516 |
Male | 723 | 17.9 | ± 19.6 | 17.0 | -7.0 | 59.0 | 235 | 958 |
Female | 382 | 14.5 | ± 17.3 | 12.0 | -7.0 | 59.0 | 176 | 558 |
Race/Ethnicity vs Paced Auditory Serial Addition Task (PASAT) Total Dyad Responses - 1.6 second trial
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Paced Auditory Serial Addition Task (PASAT) Total Dyad Responses - 1.6 second trial
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Paced Auditory Serial Addition Task (PASAT) Total Dyad Responses - 1.6 second trial
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 23.4 | ± 15.7 | 22.0 | -3.0 | 59.0 | 411 | 1,516 |
Native American | 18 | 18.7 | ± 13.5 | 15.0 | 3.0 | 56.0 | 10 | 28 |
Asian | 61 | 29.9 | ± 15.2 | 28.0 | -3.0 | 59.0 | 28 | 89 |
Black | 103 | 15.7 | ± 13.5 | 15.0 | -3.0 | 59.0 | 69 | 172 |
Hispanic | 77 | 20.8 | ± 15.0 | 20.0 | 0.0 | 52.0 | 39 | 116 |
White | 841 | 24.2 | ± 15.8 | 23.0 | -3.0 | 59.0 | 261 | 1,102 |
Other | 5 | 26.0 | ± 13.0 | 31.0 | 8.0 | 38.0 | 4 | 9 |
Race/Ethnicity vs Paced Auditory Serial Addition Task (PASAT) Total Dyad Responses - 1.6 second trial
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Paced Auditory Serial Addition Task (PASAT) Total Dyad Responses - 1.6 second trial
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 17.1 | ± 18.3 | 16.0 | -7.0 | 59.0 | 411 | 1,516 |
Native American | 18 | 11.4 | ± 14.1 | 11.5 | -6.0 | 49.0 | 10 | 28 |
Asian | 61 | 22.8 | ± 20.2 | 24.0 | -7.0 | 59.0 | 28 | 89 |
Black | 103 | 9.2 | ± 14.0 | 6.0 | -7.0 | 47.0 | 69 | 172 |
Hispanic | 77 | 15.2 | ± 16.9 | 14.0 | -7.0 | 57.0 | 39 | 116 |
White | 841 | 18.0 | ± 18.5 | 17.0 | -7.0 | 59.0 | 261 | 1,102 |
Other | 5 | 6.4 | ± 14.4 | 3.0 | -6.0 | 28.0 | 4 | 9 |
Race/Ethnicity vs Paced Auditory Serial Addition Task (PASAT) Total Dyad Responses - 1.6 second trial
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Paced Auditory Serial Addition Task (PASAT) Total Dyad Responses - 1.6 second trial
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 16.7 | ± 18.9 | 15.0 | -7.0 | 59.0 | 411 | 1,516 |
Native American | 18 | 11.9 | ± 15.2 | 10.5 | -6.0 | 40.0 | 10 | 28 |
Asian | 61 | 24.3 | ± 20.1 | 26.0 | -7.0 | 59.0 | 28 | 89 |
Black | 103 | 9.8 | ± 15.5 | 5.0 | -7.0 | 55.0 | 69 | 172 |
Hispanic | 77 | 13.9 | ± 17.7 | 11.0 | -7.0 | 57.0 | 39 | 116 |
White | 841 | 17.5 | ± 19.1 | 17.0 | -7.0 | 59.0 | 261 | 1,102 |
Other | 5 | -0.6 | ± 5.3 | 0.0 | -6.0 | 5.0 | 4 | 9 |